Back
About the Global Fund
People & Structures
Back
Funding Model
Investments & Results
-
Explore contributions, investments and results in our fight against AIDS, tuberculosis and malaria around the world.
- Data Explorer
- Funding Decisions
- Data Service
HIV & AIDS
Tuberculosis
Malaria
Back
News
-
12 May 2021
Global Fund 45th Board Meeting Reports Continued Progress Despite COVID-19 Pandemic -
06 May 2021
Global Fund Approves US$75 million for India’s COVID-19 Response -
14 April 2021
Indonesia, Germany and Global Fund Sign New Debt Swap Agreement to Fight TB -
13 April 2021
New Global Fund Report Shows Massive Disruption to Health Care Caused by COVID-19 in Africa and Asia
Updates
Stories
-
03 May 2021
Okinawa: Lighting a Flame for the Fight Against Infectious Diseases -
25 April 2021
In Fighting COVID-19, We Can’t Neglect Malaria -
23 April 2021
United Against Malaria -
22 April 2021
Malaria and COVID-19: Q&A with Dr. Scott Filler -
24 March 2021
On World TB Day, Crisis and Hope -
24 March 2021
Fighting Two Airborne Pandemics in India: TB and COVID-19
Back
Featured Publication
Documents by type
HIV & Malaria Rapid Diagnostic Tests
The Global Fund is working with partners and manufacturers of rapid diagnostic tests for HIV and malaria to establish market demand and support procurement of these diagnostics products and related laboratory items for implementing partners.
HIV Global Diagnostic Working Group
The HIV Global Diagnostic Working Group provides a forum to share information and align actions and communications related to improving access to quality-assured, HIV-related in vitro diagnostics for patients.
The Global Fund and the United States Agency for International Development host the working group. Members of the working group include stakeholders of various interests and mandates and include:
- African Society for Laboratory Medicine
- Centers for Disease Control and Prevention
- Clinton Health Access Initiative
- The Global Fund
- Médecins Sans Frontières
- United Nations Children's Fund
- Unitaid
- United States Agency for International Development
- President's Emergency Plan for AIDS Relief
- World Health Organization: Prequalification of In Vitro Diagnostics Program and HIV Department
The Global Fund is committed to increasing access to quality-assured rapid diagnostic tests. New suppliers interested in working with the Global Fund and other public sector buyers who would like access to our negotiated terms and pricing should contact Azizkhon Jafarov at .
Documents related to our strategy are available for download here.
-
Strategy Documents[2]
-
Rapid Diagnostic Tests Supplier and Partner Consultative Meeting Presentation (December 2018)
download in English Rapid Diagnostic Tests Supplier and Partner Consultative Meeting Presentation (December 2018) - Global Diagnostics Working Group Stakeholder and Manufacturer AIDS Medicines and Diagnostics Service Meeting Presentation (June 2016)
-
Rapid Diagnostic Tests Supplier and Partner Consultative Meeting Presentation (December 2018)
-
Reference Prices and Procurement Planning Documents[2]
-
Operational Guidance: Procurement of Malaria Rapid Diagnostic Tests through Global Fund Grants
download in English Operational Guidance: Procurement of Malaria Rapid Diagnostic Tests through Global Fund Grants | Español Directriz operativa: adquisición de pruebas de diagnóstico rápido de malaria mediante subvenciones del Fondo Mundial | Français Directives opérationnelles : achat de tests de diagnostic rapide du paludisme avec les subventions du Fonds mondial -
Pooled Procurement Mechanism Reference Pricing: Rapid Diagnostic Tests (RDTs) (July 2020)
download in English Pooled Procurement Mechanism Reference Pricing: Rapid Diagnostic Tests (RDTs) (July 2020)
-
Operational Guidance: Procurement of Malaria Rapid Diagnostic Tests through Global Fund Grants
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website. To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.